Xarelto Drug Injury Attorney
Prescribed to prevent blood clots and stroke, Xarelto (rivaroxaban) is an oral anticoagulant medication that was approved by the U.S. Food and Drug Administration (FDA) in November 2011. Over the years, the FDA has expanded the approved uses for Xarelto, approving it to treat other serious conditions caused by blood clots, including deep vein thrombosis (DVT) and pulmonary embolism (PE).
When Xarelto was first introduced to the U.S. market, it was touted as a “next generation” anticoagulant that was safer than older blood thinners (like warfarin).
Since then, however, Xarelto has been linked to some severe, potentially deadly co